These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19450182)

  • 21. [Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia--recent progress].
    Okamoto S
    Nihon Rinsho; 2009 Oct; 67(10):1944-50. PubMed ID: 19860195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.
    Hamadani M; Awan FT; Copelan EA
    Biol Blood Marrow Transplant; 2008 May; 14(5):556-67. PubMed ID: 18410898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
    Aoudjhane M; Labopin M; Gorin NC; Shimoni A; Ruutu T; Kolb HJ; Frassoni F; Boiron JM; Yin JL; Finke J; Shouten H; Blaise D; Falda M; Fauser AA; Esteve J; Polge E; Slavin S; Niederwieser D; Nagler A; Rocha V;
    Leukemia; 2005 Dec; 19(12):2304-12. PubMed ID: 16193083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.
    Cahu X; Mohty M; Faucher C; Chevalier P; Vey N; El-Cheikh J; Guillaume T; Furst S; Delaunay J; Ayari S; Moreau P; Gastaut JA; Harousseau JL; Blaise D
    Bone Marrow Transplant; 2008 Nov; 42(10):689-91. PubMed ID: 18679370
    [No Abstract]   [Full Text] [Related]  

  • 25. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
    Aversa F; Terenzi A; Tabilio A; Falzetti F; Carotti A; Ballanti S; Felicini R; Falcinelli F; Velardi A; Ruggeri L; Aloisi T; Saab JP; Santucci A; Perruccio K; Martelli MP; Mecucci C; Reisner Y; Martelli MF
    J Clin Oncol; 2005 May; 23(15):3447-54. PubMed ID: 15753458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.
    McClune BL; Weisdorf DJ; Pedersen TL; Tunes da Silva G; Tallman MS; Sierra J; Dipersio J; Keating A; Gale RP; George B; Gupta V; Hahn T; Isola L; Jagasia M; Lazarus H; Marks D; Maziarz R; Waller EK; Bredeson C; Giralt S
    J Clin Oncol; 2010 Apr; 28(11):1878-87. PubMed ID: 20212255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Favorable outcomes after allogeneic hematopoietic stem cell transplantation in children with high-risk or advanced acute myeloid leukemia.
    Koh KN; Park M; Kim BE; Bae KW; Im HJ; Seo JJ
    J Pediatr Hematol Oncol; 2011 May; 33(4):281-8. PubMed ID: 21464766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allogeneic hematopoietic stem cell transplantation for acute myeloblastic leukemia in first remission].
    Bondarenko SN; Semenova EV; Vavilov VN; Stancheva NV; Morozova EV; Alianskiĭ AL; Babenko EV; Osipova NÉ; Zubarovskaia LS; Afanas'ev BV
    Ter Arkh; 2013; 85(7):18-25. PubMed ID: 24137943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential reduced-intensity chemotherapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia with rare cytogenetic abnormalities transformed from Fanconi anemia.
    Inoue A; Mori A; Yamazaki S; Suzuki R; Takitani K; Tamai H
    Pediatr Int; 2018 Sep; 60(9):893-894. PubMed ID: 30255979
    [No Abstract]   [Full Text] [Related]  

  • 31. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
    Bachanova V; Weisdorf D
    Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mini-transplant for acute myeloblastic leukemia and myelodysplastic syndrome].
    Kanda Y
    Nihon Rinsho; 2003 Sep; 61(9):1565-72. PubMed ID: 14515725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
    Petersen FB; Ford CD
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S7-9. PubMed ID: 19561415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukaemia in children.
    Rodríguez-Romo L; Mancias-Guerra C; González-Llano O; Jaime-Pérez JC; Martínez-Cabriales S; García-Rodríguez F; Gómez-Almaguer D
    Br J Haematol; 2010 Oct; 151(2):200-2. PubMed ID: 20738308
    [No Abstract]   [Full Text] [Related]  

  • 35. Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia.
    Schneidawind D; Federmann B; Faul C; Vogel W; Kanz L; Bethge WA
    Ann Hematol; 2013 Oct; 92(10):1389-95. PubMed ID: 23652585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
    Grigg AP; Gibson J; Bardy PG; Reynolds J; Shuttleworth P; Koelmeyer RL; Szer J; Roberts AW; To LB; Kennedy G; Bradstock KF
    Biol Blood Marrow Transplant; 2007 May; 13(5):560-7. PubMed ID: 17448915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
    Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
    J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies.
    Liu H; Stock W; Bishop MR
    Curr Opin Hematol; 2013 Mar; 20(2):115-22. PubMed ID: 23385613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience.
    Leong CF; Cheong SK; Fadilah SA; Ainoon O; Hamidah NH
    Med J Malaysia; 2003 Jun; 58(2):229-35. PubMed ID: 14569743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.
    Ringdén O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hägglund H; Omazic B; Svenberg P; Dahllöf G; Mattsson J; Ljungman P; Remberger M
    J Intern Med; 2013 Aug; 274(2):153-62. PubMed ID: 23432209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.